Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
10.4 %
$ 147 M
Market Cap
-0.68
P/E
IKT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative IKT - Inhibikase Therapeutics, Inc.
6.73 M
LAST VALUE
1.71%
2 YEAR CAGR
21.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR